Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
New analysis indicates that Novartis drug Gilenya shows significant early effect on reducing brain volume loss at 6 months
Lack of information about multiple sclerosis in children can impact parents' sense of competency and satisfaction within the couple.
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.
The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis.
New Clues to Link Between MS Drug Tysabri and Rare Brain Disease
Neuropsychological rehabilitation does not improve cognitive performance but reduces perceived cognitive deficits in patients with multiple sclerosis: a randomised, controlled, multi-centre trial.
Differential targeting of IL-2 and T cell receptor signaling pathways selectively expands regulatory T cells while inhibiting conventional T cells.
CMT4D (NDRG1 mutation): genotype-phenotype correlations.
Therapeutic plasma exchange in neuromyelitis optica: A case series.
Improving the quality of mental health care in Multiple Sclerosis.
Multiple sclerosis: Lessons from molecular neuropathology.
JCV-negative natalizumab-associated progressive multifocal leukoencephalopathy: a clinico-radiological diagnosis.
A high throughput flow gradient LC-MS/MS method for simultaneous determination of fingolimod, fampridine and prednisone in rat plasma, application to in vivo perfusion study.
Oligodendrocyte progenitor cells: the ever mitotic cells of the CNS.
Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics.
Initial investigation of the blood-brain barrier in MS lesions at 7 tesla.
Anti-interleukin-2 receptor alpha for multiple sclerosis?
A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis.
Impaired adult myelination in the prefrontal cortex of socially isolated mice.
Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors Remyelinate the Brain and Rescue Behavioral Deficits following Radiation.
Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.
The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation.
Dynamic change in magnetic resonance imaging of patients with neuromyelitis optica.
Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders.
Astrogliosis During Acute and Chronic Cuprizone Demyelination and Implications for Remyelination.
Pages
« first
‹ previous
…
349
350
351
352
353
354
355
356
357
…
next ›
last »